SCHEMBL7212141

SCHEMBL7212141

CC(=O)OSCCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.53
ALDH1A1 P00352 4/20 0.52
KEAP1 Q14145 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
HDAC4 P56524 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27517619 0.91 PTGS2 (0.49) PTGS2ALDH1A1TDP1SMN1; SMN2HDAC2
SCHEMBL10519643 0.82 ALDH1A1 (0.52) PTGS2ALDH1A1TDP1MAPK1FFAR1
SCHEMBL28722296 0.81 TDP1 (0.46) PTGS2ALDH1A1KEAP1TDP1SMN1; SMN2
SCHEMBL5640444 0.81 ALDH1A1 (0.51) PTGS2ALDH1A1TDP1SMN1; SMN2MAPK1
SCHEMBL7403225 0.78 KEAP1 (0.47) PTGS2ALDH1A1KEAP1TDP1SMN1; SMN2
SCHEMBL6441709 0.77 THRB (0.46) PTGS2ALDH1A1KEAP1TDP1SMN1; SMN2
SCHEMBL5668820 0.76 ALDH1A1 (0.49) ALDH1A1TDP1SMN1; SMN2MAPK1NPC1
SCHEMBL3411003 0.75 TDP1 (0.56) PTGS2ALDH1A1KEAP1TDP1HDAC2
SCHEMBL10519638 0.75 TDP1 (0.56) PTGS2ALDH1A1KEAP1TDP1HDAC2
Acetone SCHEMBL3486840 0.74 ALDH1A1 (0.70) ALDH1A1KEAP1TDP1SMN1; SMN2HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1234718-C New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2006-01-04 CN disclosed
CN-1464880-A New macrolides with antibacterial activity BASILEA PHARMACEUTICA AG (CH) 2003-12-31 CN disclosed
EP-1313751-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY Basilea Pharmaceutica AG (CH) 2003-05-28 EP disclosed
WO-2002016380-A1 NEW MACROLIDES WITH ANTIBACTERIAL ACTIVITY BASILEA PHARMACEUTICA AG (CH) 2002-02-28 WO disclosed
EP-0792264-B1 SULFUR-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORP (US) 2002-02-27 EP disclosed
US-5744467-A ANTICHOLESTEROL AGENTS SCHERING CORPORATION 1998-04-28 US disclosed
EP-0792264-A1 SULFUR-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1997-09-03 EP disclosed
US-5633246-A Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORPORATION (US) 1997-05-27 US disclosed
US-5624920-A Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORPORATION (US) 1997-04-29 US disclosed
WO-1996016037-A1 SULFUR-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORPORATION (US) 1996-05-30 WO disclosed
EP-0310484-A1 Derivatives of alkadienes, their preparations, medicinal compositions containing them, and intermediates RHONE-POULENC SANTE (FR) 1989-04-05 EP disclosed